Sagilia 1 mg tablete
Name | Sagilia 1 mg tablete |
---|---|
Marketing Authorisation Number | HR-H-184246775 |
Active Substance | razagilintartarat |
Composition | svaka tableta sadrži 1 mg razagilina (u obliku razagilintartarata) |
Pharmaceutical Form | tableta |
Manufacturer | Medochemie Ltd., Limassol, Cipar |
Marketing Authorisation Holder | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
Marketing Authorisation Date | 11.03.2020 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/20-02/17 |
Registration Number | 381-12-01/38-20-03 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | N04BD02 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Public Assessment Report | download |